Karyopharm Therapeutics Inc. 401(K) Plan — Form 5500 plan (Karyopharm Therapeutics Inc.)
Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Karyopharm Therapeutics Inc. 401(K) Plan is a benefit plan reported by Karyopharm Therapeutics Inc. under EIN 26-3931704 and plan number 001. The latest loaded filing year is 2023. The filing reports 597 participants and $46,052,253 in end-of-year plan assets, where available in the loaded dataset.
Key reported metrics
- Plan sponsor
- Karyopharm Therapeutics Inc.
- EIN
- 26-3931704
- Plan number
- 001
- Plan type
- 2
- Location
- Newton, MA
- Latest filing year
- 2023
- Participants
- 597
- End-of-year plan assets
- $46,052,253
Form 5500 filing history
| Filing year | Participants | Schedules | Filing |
|---|---|---|---|
| 2023 | 597 | H, C | 20240910114713NAL0009880848001 |
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $46,052,253
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $46,052,253
- Net assets (BOY)
- $36,042,620
Income & contributions
- Employer contributions
- $3,213,687
- Participant contributions
- $6,252,031
- Total contributions
- $11,512,443
- Total income / additions
- $19,092,186
Expenses & distributions
- Benefits paid
- $9,007,580
- Administrative expenses
- $50,144
- Total expenses
- $9,082,553
- Net increase / (decrease)
- $10,009,633
Service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. | Year |
|---|---|---|---|---|
| Fidelity Investments Institutional | RECORDKEEPER | $50,144 | $0 | 2023 |